1. Introduction {#sec1}
===============

*Entamoeba histolytica* is the protozoan parasite causative of human amoebiasis \[[@B1]\]. Replication in *E. histolytica* is inhibited by aphidicolin \[[@B2], [@B3]\], a specific inhibitor of mammalian *α*, *δ* and *ε* DNA polymerases. Additionally, *EhMCM2*, *EhMCM3*and *EhMCM5*genes, whose products are part of the helicase complex, have been cloned and characterized \[[@B4], [@B5]\]. Although nuclear *α* and *δ* DNA polymerase sequences are present in *E. histolytica* genome \[[@B6]\], DNA polymerase encoding genes have not been isolated or characterized and DNA replication processes are poorly understood in this parasite.

In eukaryotes, replicative DNA polymerases are grouped in two families: (1) family A, which includes *γ* DNA polymerases of animals and fungi, and Pol I-like DNA polymerases responsible for mitochondrial DNA replication in plants and slime mold. (2) family B comprises the *α*, *δ* and *ε* DNA polymerases involved in nuclear DNA replication \[[@B7]--[@B9]\], archaebacterial, viral, bacteriophage DNA polymerases such as those present in phages T4 and RB69 and DNA polymerases encoded in fungi and plant mitochondrial plasmids \[[@B10]\]. Commonly, the fungal plasmids are linear and they have been frequently found in filamentous fungi \[[@B11]\]. Transcription and replication of linear plasmids are initiated in terminal inverted repeats by a plasmid encoded phage-like single subunit RNA polymerase and by a DNA polymerase of the family B, respectively \[[@B12]\]. Replication in these plasmids is thought to occur by a protein-primed mechanism, similar to that described for *Bacillus subtilis*phage phi29 \[[@B13]\]. The B DNA polymerases are distinguished by the presence of up to six common regions in their amino acid sequences (boxes I to VI). The most conserved regions (I and II) include aspartic acid residues essential to catalytic polymerase activity \[[@B10]\].

Although it has been reported that *E. histolytica*had a secondary mitochondrial lost \[[@B14]\], no genes encoding *γ* DNA polymerase responsible for mitochondrial DNA replication have been detected \[[@B6]\]. However, trophozoites carry mitosomes, a mitochondrial cytoplasmic remnant organelle lacking DNA \[[@B15], [@B16]\], and crypton and EhkO \[[@B17]--[@B20]\], two DNA-containing cytoplasmic organelles, with a double membrane. Crypton is a 0.5 to 1 *μ*m organelle that carries the mitochondrial chaperonin Hsp60 \[[@B17], [@B18]\], whereas EhkO varies from 0.5 to 5 *μ*m and it has the EhPFO enzyme \[[@B21]\]. Some authors have suggested that crypton and EhkO could be the same structure \[[@B18]\]; however, their morphological and biochemical characteristics need to be better studied to define this.

The mechanism of DNA replication and the proteins and genes involved in this process in *E. histolytica* are unknown. To better understand the DNA replication process in this parasite we have initiated the search and study of its DNA polymerase genes. Here, we report the identification of a gene family (*Ehodp1*, *Ehodp2*, *Ehodp3*and *Ehodp4*) encoding putative *E. histolytica*DNA polymerases. All of them correspond to the family B, with a high similarity to fungi and plant DNA polymerases encoded in mitochondrial plasmids. RT-PCR experiments indicated that the four genes are expressed in trophozoites. Additionally, in situ PCR assays demonstrated that *Ehodp1*gene is located in nuclei and in cytoplasmic DNA-containing structures. By confocal microscopy using polyclonal antibodies against a recombinant EhODP1 fragment, the EhODP1 polypeptide was only detected in cytoplasmic structures, but not in nuclei.

2. Materials and Methods {#sec2}
========================

2.1. *E. histolytica* Cultures {#sec2.1}
------------------------------

Trophozoites of *E. histolytica*clone A were axenically cultured in TYI-S-33 medium at 37°C and harvested during the exponential growth phase as described \[[@B22]\]. For purification of EhkOs, the medium was supplemented with 2 *μ*Ci/mL \[methyl-^3^H\]-Thymidine (Amersham) for 48 hours \[[@B23]\].

2.2. Search of Genes Encoding DNA Polymerases in the *E. histolytica* Genome Databases {#sec2.2}
--------------------------------------------------------------------------------------

To identify a DNA polymerase encoding gene, a BLAST search was performed in the *E. histolytica* genome databases at The Sanger Institute <http://www.sanger.ac.uk/> and Pathema from The J. Craig Venter Institute <http://www.jcvi.org/>. As query, we used the polypeptide sequence of the *Gelasinospora sp* DNA polymerase encoded on mitochondrial plasmids \[UniProt Knowledgebase (UniProtKB)/TrEMBL accession number (AN) O03684\] and the WU-BLAST version 2.0 program and BLOSUM62 matrix. DNA sequences were translated to proteins with the Translate tool at the ExPASy Proteomics Server <http://www.expasy.org>/. BLAST search for each EhODP polypeptide sequence was done with BLASTP 2.2.14 algorithm in the UniProtKB at the ExPASy Proteomics server of the Swiss Institute of Bioinformatics using the BLOSUM62 matrix. Alignments were performed with ClustalW version 1.83 algorithm at the European Bioinformatics Institute (EBI, <http://www.ebi.ac.uk/Tools/clustaw2/index.html>).

2.3. Semiquantitative RT-PCR Assays {#sec2.3}
-----------------------------------

Total RNA was isolated with TRIzol (Invitrogen). cDNA was synthesized with 200 U of SuperScript II reverse transcriptase (Invitrogen) and 40 U of RNasin ribonuclease inhibitor (Promega). PCR assays were performed with 3 *μ*L of cDNA mixture, 400 *μ*M dNTPs, 2 mM MgCl~2~, 200 nM of specific primers for each gene and 4 U of *Taq*DNA polymerase (Invitrogen). For *Ehodp1*gene we used *odp1*-f (forward), 5′-GAAGATCTGCCAATCCCCACAAAACGTCCCAC-3′, and *odp1*-r (reverse), 5′-GGAATTCTTATTGCGGTTCGATATTTTCTAAGTT-3′ primers (Tm of 59°C), containing the *Bgl*II and *Eco*RI restriction sites at their 5′ ends, respectively. For *Ehodp2*gene we used the primers *odp2*-f, 5′-ATCGTCGAAATACAAGACAAAA-3′ and *odp2*-r, 5′-TCTTTGATATTCTTCATCACTGG-3′ (Tm of 54°C). For *Ehodp3*gene we used *odp3*-f, 5′- TGAAAGAAGAGAGAAATACAAAG -3′ and *odp3*-r, 5′-ATCACTAACTCTTTCTTCCCC-3′ primers (Tm of 54°C). For *Ehodp4* we used *odp4*-f, 5′-ATCTGACTTAGATGGCTATGCTGA-3′, and *odp4*-r, 5′-GTCATTAAGGGGATCTGGTG-3′ oligonucleotides (Tm of 54°C). As an internal control, we used (sense) 5′-AGCTGTTCTTTCATTATATGC-3′ and (antisense) 5′-TTCTCTTTCAGCACTAGTGGT-3′ actin oligonucleotides (Tm of 54°C). PCR conditions were; 94°C (5 minutes), followed by 29 cycles at 94°C (30 seconds), annealing at specific Tm for each pair of primers (60 seconds) and extension at 72°C (60 seconds). RT-PCR products were separated by 6% PAGE gels in 0.5  × TBE (90 mM Tris, 90 mM H~3~BO~3~, 2 mM EDTA, pH 8.3), stained with ethidium bromide and visualized with a UV transilluminator (Gel Doc Documentation System, Bio-Rad). For densitometry analysis we used the Quantity One software version 4.6.1 (Bio-Rad).

2.4. Cloning of a 504 bp DNA Fragment from the Ehodp1 Gene {#sec2.4}
----------------------------------------------------------

A 504 bp DNA fragment from contig1 sequence (from 232 to 735 bp) was PCR amplified from *E. histolytica*total DNA using 200 nM of each primer (*odp1*-f and *odp1*-r), 400 *μ*M dNTPs, 2 mM MgCl~2~ and 2 U of *Taq*DNA polymerase. PCR was performed using the conditions mentioned above. Amplified DNA was purified and cloned into pRSET A vector (Invitrogen) to generate the recombinant pRSET A-*Ehodp1*-504 plasmid (prEhodp1). Sequencing of cloned DNA was carried out using the Big Dye Terminator kit version 3.1 (Applied Biosystems) in an Automated DNA Sequencer (310 Genetic Analyzer, Applied Biosystems). Nucleotide sequence data of the *Ehodp1*gene is available in the GenBank database under the accession number EU423197.

2.5. Expression and Purification of the Recombinant rEhODP1-168 Polypeptide in *Escherichia coli* {#sec2.5}
-------------------------------------------------------------------------------------------------

*E. coli*BL21(DE3)pLysS (Invitrogen) competent cells were transformed with prEhodp1 plasmid. rEhODP1-168 polypeptide production was induced with 1 mM isopropyl-*β*-D-thiogalactopyranoside (IPTG) for 3 hours at 37°C. Cells were harvested, resuspended in lysis buffer (6 M guanidine-HCl, 0.1 M NaH~2~PO~4~, 0.01 M Tris-HCl, pH 8.0) and disrupted by sonication at 4°C. Recombinant polypeptide was purified under denaturing conditions by immobilized metal affinity chromatography (IMAC) through a Ni^2+^-NTA agarose column (Qiagen) in buffer D (8 M urea, 100 mM NaH~2~PO~4~, 10 mM Tris HCl, pH 5.9) and buffer E (8 M urea, 100 mM NaH~2~PO~4~, 10 mM Tris HCl, pH 4.5), following the manufacturer\'s protocol. Then, rEhODP1-168 polypeptide purification was improved by electroelution from preparative 15% SDS-PAGE gels using a Model 422 Gel Electro-eluter (Bio-Rad).

2.6. Two Dimensional-Gel Electrophoresis and MALDI-TOF Analysis {#sec2.6}
---------------------------------------------------------------

Purified fractions, obtained from the Ni^2+^-NTA-agarose affinity chromatography, were analyzed in 2D-gels. Isoelectric focusing was performed with ZOOM strips (linear pH 3--10 gradient) in an XCell SureLock Mini-Cell system (Invitrogen) at 200 V (20 minutes), 450 V (15 minutes), and 2,000 V (30 minutes). Second dimension was done through a 15% SDS-PAGE with a Mini-Protean II system (Bio-Rad). Then, gels were Coomassie Brilliant Blue stained and selected spots were cut and sent to the Protein Chemistry Core Facility at Columbia University for analysis by mass spectrometry in a MALDI-TOF system.

2.7. Generation of Rat Polyclonal Antibodies Against rEhODP1-168 Polypeptide and Western Blot Assays {#sec2.7}
----------------------------------------------------------------------------------------------------

Wistar rats were three times intramuscularly immunized with 15 *μ*g of purified rEhODP1-168 polypeptide mixed with diluted 1 : 10 (v/v) Titer Max Gold (CytRx Corporation) in PBS at 15 days intervals. Then, immune serum was collected 14 days after last immunization. Rats were bled before the first immunization to obtain preimmune serum. For Western blot assays, purified rEhODP1-168 polypeptide was separated by 15% SDS-PAGE and transferred to a nitrocellulose membrane. Membranes were blocked with 3% (w/v) nonfat milk in PBS for one hour \[[@B24]\]. Immunodetection of His-tagged polypeptide was done by incubation with 0.3 *μ*g/mL mouse anti-6His monoclonal antibodies (Roche) for 1 hour at 37°C. Membranes were washed 3 times with PBS, followed by incubation with horseradish peroxidase-conjugated goat anti-mouse IgG secondary polyclonal antibodies (Zymed) (1 : 2,000) at room temperature (RT) for 1 hour. Immunoreactive bands were visualized using 3, 3′-diaminobenzidine and 0.025% (v/v) H~2~O~2~ \[[@B25]\]. For Western blot of trophozoite total extracts supplemented with 1 × complete protease inhibitors (Roche) and EhkO-enriched fraction, proteins were separated through 10% SDS-PAGE and transferred to nitrocellulose membranes that were treated as mentioned above. Then, membranes were incubated with either rat anti-rEhODP1-168 polyclonal antibodies or preimmune serum (1 : 1,000) overnight at 4°C, and revealed as described \[[@B25]\].

2.8. Immunofluorescence and Confocal Microscopy {#sec2.8}
-----------------------------------------------

Trophozoites adhered on cover slips, were paraformaldehyde fixed (4% w/v) at RT (1 hour) and treated with 50 mM NH~4~Cl at 37°C (1 hour). Then, cells were permeabilized with acetone at −20°C (7 minutes), immersed in blocking solution (2% BSA, w/v, in PBS) at RT (2 hours) and incubated with rat anti-rEhODP1-168 antibodies (1 : 500) at 4°C overnight. Next, they were washed with PBS, incubated with fluorescein-labeled goat anti-IgG rat secondary antibodies (1 : 1,000) in blocking solution at RT (2 hours), washed with PBS, counterstained with 20 *μ*g/mL propidium iodide (PI) (Fluka) for 5 minutes, and observed through a Leika DM-IRE2 confocal microscope. As a negative control, cells were treated as above, but incubation with anti-rEhODP1-168 antibodies was omitted or preimmune serum was used.

2.9. Isolation of an EhkO-Enriched Fraction {#sec2.9}
-------------------------------------------

EhkOs were purified from \[^3^H\]-Thymidine labeled trophozoites as described \[[@B23]\]. Cells were washed with PBS and resuspended in 8 volumes of buffer A (10 mM EDTA, 10 mM DTT, 10 mM HEPES, pH 7.9) containing 1× complete protease inhibitors (Roche) and 250 mM sucrose. Then, cells were gently disrupted on ice using a Potter homogenizer and centrifuged at 160 ×g for 10 minutes. The supernatant was centrifuged at 10,000 ×g for 10 minutes at 4°C, and the pellet was resuspended in 15% (v/v) Nycodenz (Axis-Shield) in buffer A and top loaded on a Nycodenz discontinuous gradient (30%, 40% and 50%, all v/v). Then, pellet was centrifuged at 13,000 ×g for 60 minutes at 4°C. Fractions of 0.5 mL were collected with a DensiFlow II C system (Buchler Instruments) and a RediFrac 1,000 fraction collector (Bio-Rad). 100 *μ*L aliquots of each fraction were 10% (w/v) TCA precipitated and their radioactivity content was determined in a LS6500 liquid scintillation counter (Beckman). EhkO-containing fractions were identified by \[^3^H\]-Thymidine incorporation.

2.10. In Situ PCR {#sec2.10}
-----------------

Assays were performed according to protocols included in the In Situ-PCR (*IS*-PCR) manual (Perkin-Elmer). Exponentially growing trophozoites were attached to glass slides, washed with PBS at 37°C and paraformaldehyde fixed (4% w/v) at RT for 60 minutes. Fixed trophozoites were incubated in 20 mM HCl (15 minutes), washed twice in PBS (5 minutes), incubated in 0.01% (v/v) Triton X-100 (90 seconds), washed in PBS and treated with 1 *μ*g/mL proteinase K at 40°C (25 minutes). Next, cells were dehydrated in ethanol solutions (30%, 50%, 70% and 100%, v/v) at 4°C (5 minutes). For *IS*-PCR, samples were covered with 50 *μ*L of reaction mixture containing 200 *μ*M dNTPs, 400 *μ*M of each odp1-f and odp1-r primers (described in Materials and Methods, [Section 2.3](#sec2.3){ref-type="sec"}), 4.5 mM MgCl~2~, 10 U of Ampli*Taq* DNA Polymerase*IS* (Perkin-Elmer) and 0.1 *μ*L of Cy5-dCTP (Amersham). PCR conditions were as follows: one cycle at 94°C (3 minutes), followed by 30 cycles of annealing at 59°C (60 seconds) and extension at 72°C (60 seconds). A final extension step was carried out at 72°C (7 minutes). Then, samples were fixed with 2% (w/v) paraformaldehyde at RT (5 minutes), washed with PBS, incubated with 25 mg/mL RNase A (Roche) (20 minutes), washed with PBS, counterstained with 20 *μ*g/mL PI (5 minutes), and observed through a Leika DM-IRE2 confocal microscope. *IS*-PCR negative controls were carried out, one without *Taq*DNA polymerase and the second containing all the reaction components except for oligonucleotides.

3. Results {#sec3}
==========

3.1. Identification of Four Genes Encoding *E. histolytica* DNA Polymerases of Family B {#sec3.1}
---------------------------------------------------------------------------------------

*E. histolytica* has DNA-containing cytoplasmic organelles that could be related to mitochondrion. Therefore, we performed a BLAST search in the *E. histolytica* genome databases using as query several *γ* DNA polymerase sequences from different organisms, but we did not find any related sequence to them. Then, we employed as query the *Gelasinospora*DNA polymerase sequence (UniProtKB/TrEMBL AN O03684) encoded by the mitochondrial linear plasmid Gel-kal \[[@B26]\]. First, we found in the Wellcome Trust Sanger Institute database a 3,462 bp ORF sequence annotated as contig1, which encodes for a 1,154 amino acid polypeptide with a 135.5 kDa predicted molecular mass. This polypeptide sequence displayed 20% to 28% identity and 39% to 44% similarity to organellar DNA polymerases of family B encoded in mitochondrial plasmids and 33% identity and 53% similarity to a*Trichomonas vaginalis* putative DNA polymerase ([Table 1](#tab1){ref-type="table"}). We called this gene *E. histolytica*organellar-like DNA polymerase 1 (*Ehodp1*). Then, using the *Ehodp1*sequence as query we detected at Pathema, three other *E. histolytica*related sequences: EHI_196700/GenBank ID: XM_643104 (*Ehodp2*) that has 3,696 bp and encodes for a putative 1,231 amino acid polypeptide (147.7 kDa), EHI_132860/GenBank ID: XM_644753 (*Ehodp3*) with 3,273 bp and encodes for a 1,090 amino acid polypeptide (129.2 kDa) and EHI_164190 (*Ehodp4*) that has 3,897 bp and encodes for a 1,278 amino acid protein (149.5 kDa) ([Figure 1](#fig1){ref-type="fig"}). EhODP1 is 51% identical to EhODP2 and EhODP3, and 63% to EhODP4 and it shows 69%, 67% and 76% similarity to EhODP2, EhODP3 and EhODP4, respectively.

3.2. Structural Organization of Putative *E. histolytica* DNA Polymerases {#sec3.2}
-------------------------------------------------------------------------

The alignment of EhODP1, EhODP2, EhODP3 and EhODP4 protein sequences with other DNA polymerases of family B with the ClustalW program, showed in EhODP amino acid sequences the presence of I, II and III conserved boxes described in DNA polymerases from other organisms (Figures [2](#fig2){ref-type="fig"}and [3](#fig3){ref-type="fig"}) \[[@B12], [@B27]\]. Boxes I and II contain part of the catalytic domain, which includes two aspartic acid residues that interact with Mg^2+^ ions \[[@B28]\]. In EhODP1, EhODP2, EhODP3 and EhODP4, the corresponding aspartic acid residues are D1040 and D795, D1093 and D848, D952 and D707, and D1140 and D895, respectively (Figures [1](#fig1){ref-type="fig"}and [3(a)](#fig3){ref-type="fig"}).

Interestingly, we also identified here two other novel boxes (A and B) in EhODP sequences that we also located in fungi mitochondrial plasmids and in the putative *T. vaginalis* DNA polymerase (Figures [1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}and [3(b)](#fig3){ref-type="fig"}). In EhODP1, Box A (IIFKDTLALIPTSISNFKTFFKLDGKYEKEIFPY) spans from I616 to Y649, in EhODP2 from I669 to Y702, in EhODP3 from I528 to Y561 and in EhODP4 from I716 to Y749. Box B in EhODP1 (FNTEKYCEYYCLRDVLVLREGFLKYK) spans from F697 to K722, while in EhODP2, EhODP3 and EhODP4, box B corresponds to the regions located at F750 to K775, F609 to K634 and F797 to K822, respectively.

Then, using the Simple Modular Architecture Research Tool (SMART), we found in EhODPs the characteristic DNA_pol_B\_2 (PF03175) domain of organellar and viral DNA polymerases of family B ([Figure 1](#fig1){ref-type="fig"}). In EhODP1 this domain is located at amino acids 570 to 1042 (e value 1.1 × 10^−11^), in EhODP2 at amino acids 621 to 1095 (e value 1.9 × 10^−15^), in EhODP3, at amino acids 480 to 954 (e value 1 × 10^−10^) and in EhODP4 at amino acids 670 to 1142 (e value 4.3 × 10^−10^). In addition, we found in them the 3′- 5′exonuclease II domain \[[@B29]\] ([Figure 3](#fig3){ref-type="fig"}). The presence of boxes I, II, III, A and B in the four EhODP polypeptides, conserved in DNA polymerases encoded in mitochondrial plasmids, as well as the detection of the 3′-5′ exonuclease II domain, strongly suggests that these *E. histolytica* polymerases constitute a family of putative organellar DNA polymerases belonging to family B.

3.3. Transcription of the Ehodp1, Ehodp2, Ehodp3 and Ehodp4 Genes in *E. histolytica* Trophozoites {#sec3.3}
--------------------------------------------------------------------------------------------------

To determine if *Ehodp*genes were expressed in trophozoites, we performed RT-PCR assays with specific oligonucleotide pairs for each gene. Results showed that the amplified products presented the expected 524, 317, 149 and 376 bp sizes for *Ehodp1*, *Ehodp2, Ehodp3*and *Ehodp4*genes, respectively ([Figure 4(a)](#fig4){ref-type="fig"}), suggesting that the four *Ehodp*genes are transcriptionally active. The expression level of each gene was measured by semiquantitative RT-PCR (Figures [4(b)](#fig4){ref-type="fig"}--[4(d)](#fig4){ref-type="fig"}) and data were normalized against the amount of actin transcript simultaneously obtained. We calculated the relative abundance of the *Ehodp* genes considering *Ehodp1* gene expression level as 100%. Thus, *Ehodp2* exhibited 96.7%, *Ehodp4* showed 35%, while *Ehodp3* was expressed only at 3.7%. Negative RT-PCR controls with the same RNA were performed for each gene in the same conditions, but without reverse transcriptase ([Figure 4(a)](#fig4){ref-type="fig"}).

3.4. Localization of the Ehodp1 Gene in Nuclei and Cytoplasmic DNA-Containing Structures by In Situ PCR {#sec3.4}
-------------------------------------------------------------------------------------------------------

To determine the cellular location of *Ehodp1* gene, we amplified by *IS-*PCR a specific DNA fragment of this gene in fixed and permeabilized trophozoites. Cells were stained with propidium iodide to detect DNA-containing organelles ([Figure 5](#fig5){ref-type="fig"}, PI). Through confocal microscope, we observed amplification of *Ehodp1*DNA in both nuclei and cytoplasmic organelles (Figures [5(a)](#fig5){ref-type="fig"}, [5(b)](#fig5){ref-type="fig"}, Cy5). Merging of fluorescent signals showed the colocalization of DNA and the amplification of *Ehodp1*in both organelles (Figures [5(a)](#fig5){ref-type="fig"}, [5(b)](#fig5){ref-type="fig"}, M). As negative controls, we alternatively performed reactions without *Taq*DNA polymerase and without *Ehodp1* specific oligonucleotides. No fluorescent signals were obtained in these cases (Figures [5(c)](#fig5){ref-type="fig"}, [5(d)](#fig5){ref-type="fig"}, Cy5). Integrity of trophozoites was confirmed by Nomarsky microscopy ([Figure 5](#fig5){ref-type="fig"}, MN). These results demonstrate that *Ehodp1*gene is located in nuclei and in cytoplasmic DNA-containing structures that may correspond to EhkOs \[[@B19]--[@B21]\] or cryptons \[[@B17], [@B18]\], or both.

3.5. Expression of a Recombinant EhODP1 Polypeptide {#sec3.5}
---------------------------------------------------

To initiate the characterization of the EhODP gene family, we cloned an *Ehodp1* 504 bp DNA fragment to obtain the recombinant plasmid prEhodp1 that was used to transform *E. coli*BL21(DE3)pLysS cells to produce a histidine-tagged rEhODP1-168 polypeptide (23.7 kDa). Electrophoretic analysis of proteins from transformed bacteria revealed the presence of 23 and 33 kDa induced bands ([Figure 6(a)](#fig6){ref-type="fig"}). Both polypeptides copurified when extracts from induced bacteria were passed through a Ni^2+^-NTA-agarose column under denaturing conditions ([Figure 6(b)](#fig6){ref-type="fig"}). Then, the recombinant protein was detected by mouse monoclonal antibodies against the 6His tag. Antibodies only recognized the 33 kDa band (Figures [6(c)](#fig6){ref-type="fig"}, [6(d)](#fig6){ref-type="fig"}), and they did not react with the 23 kDa band. To obtain further data to identify the rEhODP1-168 polypeptide, we analyzed the purified fraction by 2D gels. Both proteins in the fraction presented a closely related isoelectric point to the expected value of 4.5 ([Figure 6(e)](#fig6){ref-type="fig"}). Therefore, we excised the spots from the 2D gel and performed a MALDI-TOF mass analysis. Amino acid sequences indicated that the 33 kDa polypeptide corresponded to rEhODP1-168 (Figures [6(e)](#fig6){ref-type="fig"}, [6(f)](#fig6){ref-type="fig"}), whereas the 23 kDa polypeptide ([Figure 6(e)](#fig6){ref-type="fig"}) was a histidine-rich bacterial protein, with similarity to a bacterial FKBP-type peptidyl-prolyl cis-trans isomerase. The molecular weight showed in SDS-PAGE by rEhODP1-168 could be explained by the presence of acidic residues in its sequence, which affects electrophoretic migration, as it has been described for caldesmon, tropomyosin and calsequestrin proteins \[[@B30]\].

3.6. Immunodetection of EhODP1 in Trophozoite Total Extracts and in EhkO-Enriched Fractions {#sec3.6}
-------------------------------------------------------------------------------------------

To search for the presence of EhODPs in EhkOs, we purified these organelles ([Figure 7(a)](#fig7){ref-type="fig"}) as described in Materials and Methods \[[@B23]\] and carried out Western blots with rat anti-EhODP1 polyclonal antibodies. As a control, we used trophozoite total extracts obtained at the same time and similar conditions than EhkOs and kept at −20°C during the EhkOs purification process \[[@B23]\] and fresh prepared trophozoite total extracts. In all samples we used the proteinase inhibitor cocktail \[[@B23]\]. The antibodies recognized a 150 kDa band surrounded by a fuzzy region ([Figure 7](#fig7){ref-type="fig"}, line 2) only in fresh trophozoite extracts. In frozen trophozoites extracts they immunodetected two bands of 105 and 70 kDa, and in the EhkO-enriched fraction antibodies only detected the 70 kDa band. No signal was obtained in total protein extracts when preimmune serum was used as a negative control ([Figure 7(b)](#fig7){ref-type="fig"}, lane 5). Theoretical molecular weight of EhODP1 is 135.5 kDa. However, we observed a 150 kDa band. This difference in the molecular weight may be due to the presence of acidic residues in the protein \[[@B30]\], although posttranslational modifications cannot be disregarded. On the other hand, the 105 and 70 kDa bands that appeared in gels could be degradation products of the EhODP1 polypeptide. Hübscher et al. \[[@B31]\] reported that prokaryotic and eukaryotic replicative DNA polymerases are extremely sensitive to proteolytic cleavage, even in the presence of protease inhibitors. They detected major polymerase activity in the 110, 74 and 35 kDa polypeptides in extracts of calf thymus, human fibroblasts and HeLa cells, while in *Ustilago maydis*, *Drosophila melanogaster* and *E. coli*extracts they detected major activity in 110 and 74 kDa bands. These authors suggested that the remarkable similarity in sizes and numbers of polypeptides generated by storage of extracts may result from the conservation of localized amino acid sequences or polypeptide conformations that are particularly susceptible to proteolytic cleavage, generating active fragments of defined sizes. Spanos et al. \[[@B32]\] found a 109 kDa band corresponding to active DNA polymerase in freshly prepared homogeneous *E. coli*DNA polymerase I, but when they kept this preparation at −20°C, they also found the 76 and 72 kDa bands. In addition, they observed complete conversion of 109 kDa polypeptide to 76 and 72 kDa bands on prolonged storage at −20°C. Therefore, it could be possible that the 105 kDa polypeptide detected in frozen trophozoite extracts, had not been detected in the EhkO-enriched fraction as a result of an increase in the proteolytic degradation due to the preparations conditions and storage of the EhkO-enriched fraction.

3.7. Cellular Location of EhODP1 in Cytoplasmic DNA-Containing Structures of Fixed Trophozoites {#sec3.7}
-----------------------------------------------------------------------------------------------

We carried out the immunodetection of EhODP1 in fixed and permeabilized trophozoites, using the anti-rEhODP1-168 antibodies. Fixed trophozoites were contrasted with PI to stain DNA-containing structures. Through confocal microscope, nuclei and cytoplasmic DNA-containing structures appeared stained by PI ([Figure 8](#fig8){ref-type="fig"}). Interestingly, the anti-rEhODP1-168 antibodies reacted with structures of 4 *μ*m, but they did not stain nuclei ([Figure 8(a)](#fig8){ref-type="fig"}), giving support to the assumption that EhODP1 protein is located in DNA-containing structures that probably correspond to EhkOs. Merging images confirmed the colocalization of both red and green fluorescent signals in these structures but not in nuclei. As negative controls, we used preimmune serum ([Figure 8(b)](#fig8){ref-type="fig"}) or we omitted the first antibody (data not shown). In both cases, red fluorescence was evident but no green fluorescent signals were obtained. Cellular integrity was verified through Nomarsky microscopy.

4. Discussion {#sec4}
=============

In this work we report the existence of four genes (*Ehodp1*, *Ehodp2, Ehodp3,*and *Ehodp4*) encoding DNA polymerases in *E. histolytica*. Proteins encoded by these genes have the pol_B\_2 domain characteristic of organellar and viral DNA polymerases, which includes the 3′-5′ exonuclease II domain and the conserved boxes I, II and III, that characterize them as members of family B (Figures [1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}). In addition, these polymerases have two non previously described novel boxes, named here A and B that are shared by DNA polymerases of *T. vaginalis*and by those encoded by fungi mitochondrial plasmids (Figures [1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}). It is known that some DNA polymerase encoding plasmids can integrate into mitochondrial DNA as a consequence of DNA rearrangements produced in the mitochondrial genome. Interestingly, different phenotypes have been observed in some fungi such as senescence in *Neurospora*\[[@B33], [@B34]\] or an increase in longevity in *P. anserina*\[[@B35], [@B36]\] that contain this type of plasmids. Additionally, it is known that the DNA polymerase encoded in *K. lactis*pGKL-2 plasmid is involved in the integrity and maintenance of this plasmid \[[@B37]\].

The presence of several genes encoding organellar DNA polymerases of the family B has also been reported in the genomes of other organisms. *Agrocybe aegerita* has two pol B sequences, the *Aa-pol B* gene that is potentially functional and a disrupted *Aa-polB P1*gene. *A. chaxingu* has two pol B sequences that contain disrupted ORFs, which could encode nonfunctional enzymes \[[@B38]\]. ORFs encoded by *Ehodp genes* in *E. histolytica* conserve the catalytic domains, suggesting that they are functional. By RT-PCR we found that all four *Ehodp*genes were transcriptionally active and showed different expression levels in asynchronic cultures ([Figure 4](#fig4){ref-type="fig"}).

In situ PCR experiments showed that *Ehodp1*gene was located both in the nuclei and cytoplasmic structures that could be either EhkOs or cryptons. The finding of *Ehodp1*gene both in the nucleus and these cytoplasmic structures ([Figure 5](#fig5){ref-type="fig"}) suggests a possible interaction between them as suggested by Solis et al. \[[@B20]\]. Furthermore, EhkOs have the nuclear transcription factors EhTBP \[[@B39]\], Ehp53 \[[@B40]\], and EhCBP \[[@B41]\], and the *Ehtbp*gene was also found in the nucleus and EhkOs \[[@B39]\] as we determined for *Ehodp1*gene in the present work.

The genes encoding organellar or viral DNA polymerases have also been found in transposable elements named Mavericks \[[@B42]\]. Mavericks have an average size of 15--20 kb and are present in eukaryotic genomes including the *T. vaginalis*genome \[[@B42]\]. When we aligned the protein sequence of EhODP1 with the amino acid sequence of the DNA polymerase encoded in the *T. vaginalis Mav_Tv1.1*Maverick element, we found that they have 29% identity and 36% similarity (data not shown). However, there are no reports about the presence of Maverick-like elements in *E. histolytica*, although its genome is rich in transposable elements (nonLong Terminal Repeats) of LINES and SINES classes \[[@B43]\]. Further studies will define whether *E. histolytica*has or has not Mavericks.

Additionally, our immunolocalization experiments detected EhODP1 polypeptide in fixed trophozoites. EhODP1 protein was located in cytoplasmic DNA-containing structures but not in nuclei, and in an EhkO-enriched fraction, that was not tested for the presence of crypton organelles. For this reason we cannot discard cross-contamination between both DNA-containing organelles. Its presence in these organelles and the conservation of the DNA polymerase catalytic domain in the protein, suggest that EhODP1 could be involved in their DNA replication. We want to note here that due to the similarity in amino acid sequences between EhODP1 and EhODP4 ([Figure 3](#fig3){ref-type="fig"}), the anti-rEhODP1-168 antibodies could also recognize the *Ehodp4*gene product, which was annotated in the *E. histolytica* genome database while performing the present work. However, we decided to include EhODP4 here to have a broad panorama of the *E. histolytica*family B DNA polymerases related to mitochondrial plasmids.

5. Conclusions {#sec5}
==============

We reported here the presence of a family of four active *Ehodp*genes in the *E. histolytica*genome, encoding putative organellar DNA polymerases of family B. EhODP1, EhODP2, EhODP3, and EhODP4 conserve the 3′-5′ exonuclease II and 5′-3′ polymerization domains and show high similarity to DNA polymerases present in fungi mitochondrial plasmids. EhODP1 protein was detected in EhkOs suggesting that it could be involved in EhkO DNA replication. Interestingly, the *Ehodp1* gene was located in nuclei and cytoplasmic DNA-containing structures, indicating a close relationship between these organelles.

We thank CONACyT from Mexico for the financial support to this project. We also thank Blanca Estela Reyes Marquez for technical support in the confocal microscopy analysis.

![Alignment of the *E. histolytica* putative organellar DNA polymerases. The five conserved boxes I, II, III, A and B are framed. Identical amino acids are shown in black. Conserved changes are shown in grey. Numbers indicate the positions of amino acids in each polypeptide. Arrows locate the region used to design specific oligonucleotide pairs to amplify each gene by RT-PCR, and numbers 1, 2, 3, and 4 correspond to *Ehodp1, Ehodp2, Ehodp3* and *Ehodp4* genes, respectively. Putative DNA_pol_B\_2 (PF03175) domain (described for organellar and viral DNA polymerases of family B) is underlined. Exonuclease II domain is indicated with a dotted underlining. Arrowheads indicate the aspartic acid residues that are required for the catalytic activity.](JBB2010-734898.001){#fig1}

![Structural organization of the *E. histolytica* DNA polymerases of family B. A graphical alignment of EhOPD1, EhODP2, EhODP3 and EhODP4 with DNA polymerases of different fungi mitochondrial plasmids and a putative DNA polymerase of *T. vaginalis*was obtained based on an alignment with the ClustalW program as described in Materials and Methods. Boxes I, II and III, marked in the bars, are specific to family B. Boxes A and B correspond to two conserved regions found in fungi organellar DNA polymerases and that from *T. vaginalis*. Numbers at the beginning of bars correspond to the first methionine, and at the end of the bars to the full length for each polypeptide. Arrows indicate the organellar DNA polymerases of *E. histolytica*. *Nin*:*Neurospora intermedia*;*Gsp*:*Gelasinospora sp*;*Aim*:*Ascobolus immersus*;*Fve*:*Flammulina velutipes*;*Cpe*:*Crinipellis perniciosa*;*Aae*:*Agrocybe aegerita*;*Kla-*2:*Kluyveromyces lactis* DNA polymerase 2, found in plasmid pGKL-2;*Skl*:*Saccharomyces kluyveri*;*Pet*:*Pichia etchellsii*;*Mco*:*Morchella conica*;*Ppu*:*Porphyra purpurea*;*Pan*:*Podospora anserina*;*Kla-*1: *Kluyveromyces lactis*DNA polymerase 1, found in plasmid pGKL-1;*Pkl*:*Pichia kluyveri*;*Ehi-*1:*Entamoeba histolytica*organellar DNA polymerase 1; *Ehi-*2:*Entamoeba histolytica*organellar DNA polymerase 2;*Ehi-*3:*Entamoeba histolytica*organellar DNA polymerase 3;*Ehi-*4:*Entamoeba histolytica*organellar DNA polymerase 4;*Tva*:*Trichomonas vaginalis*.](JBB2010-734898.002){#fig2}

![Alignment of the conserved boxes identified in EhODP1, DNA polymerases encoded in fungi mitochondrial plasmids and in a *T. vaginalis* protein. (a) Amino acid sequences corresponding to boxes I, II and III which characterize the family B of DNA polymerases. (b) Amino acid sequences of boxes A and B conserved in the aligned polypeptides that were found in this work. Identical amino acids are shown in black. Conserved changes are shown in grey. Numbers correspond to the first and last residues in conserved boxes for each polypeptide. Arrows indicate the aspartic acid residues that are required for the catalytic activity of DNA polymerases. Asterisks indicate sequences corresponding to EhODPs. *Nin*:*Neurospora intermedia*;*Gsp*:*Gelasinospora sp*;*Aim*:*Ascobolus immersus*;*Fve*:*Flammulina velutipes*;*Cpe*:*Crinipellis perniciosa*;*Aae*:*Agrocybe aegerita*;*Kla-*2:*Kluyveromyces lactis* DNA polymerase 2, found in plasmid pGKL-2;*Skl*:*Saccharomyces kluyveri*;*Pet*:*Pichia etchellsii*;*Mco*:*Morchella conica*;*Ppu*:*Porphyra purpurea*;*Pan*:*Podospora anserina*;*Kla-*1: *Kluyveromyces lactis*DNA polymerase 1, found in plasmid pGKL-1;*Pkl*:*Pichia kluyveri*;*Ehi-*1:*E. histolytica*organellar DNA polymerase 1;*Ehi-*2:*E. histolytica*organellar DNA polymerase 2; *Ehi-*3:*E. histolytica*organellar DNA polymerase 3; *Ehi-*4:*E. histolytica*organellar DNA polymerase 4; *Tva*:*T. vaginalis.*](JBB2010-734898.003){#fig3}

![Expression analysis of the *Ehodp1*, *Ehodp2*, *Ehodp3* and *Ehodp4* genes. (a) RT-PCR products separated by 6% PAGE and ethidium bromide stained. Lane 1, DNA molecular markers (100 bp ladder); lanes 2, 4, 6, 8, amplified 524, 317, 149, and 376 bp DNA fragments (+) corresponding to *Ehodp1*,*Ehodp2*,*Ehodp3*and *Ehodp4*genes, respectively; lanes 3, 5, 7, 9, are the corresponding negative controls (−) for each gene in which no RT was included. (b) Semiquantitative RT-PCR. Gene products were analyzed by 6% PAGE and gels were ethidium bromide stained. Lane 1, size DNA molecular markers; lane 2, amplified 524 bp DNA fragment from *Ehodp1*; lane 3, amplified 317 bp DNA fragment from *Ehodp2;*lane 4, amplified 149 bp DNA fragment from *Ehodp3;* lane 5, amplified 376 bp DNA fragment from *Ehodp4.* (c) RT-PCR amplification product (222 bp) for actin gene used as control. (d) Densitometry analysis of the *Ehodp* gene expression shown in (b). Expression of *Ehodp1* measured in pixels was considered as 100%. Data is the average of three experiments.](JBB2010-734898.004){#fig4}

![*Ehodp1* gene localization in nuclei and cytoplasmic DNA-containing structures by in situ PCR. Trophozoites of *E. histolytica*clone A were fixed, permeabilized and used to amplify a specific DNA fragment of the *Ehodp1*gene by *IS*-PCR using Cy5-dCTP. Then, cells were RNase-treated and stained with PI and observed through a laser confocal microscope. (a)--(b) Amplification of *Ehodp1* by *IS*-PCR. (c) Negative control of *IS*-PCR carried out without *Taq*DNA polymerase. (d) Negative control of *IS*-PCR performed without *Ehodp1*specific oligonucleotides. (PI) Cells stained with propidium iodide (red channel). (Cy5) *Ehodp1* amplification products labeled with Cy5-dCTP (blue channel). (M) Merging of red and blue fluorescent signals. Squares show an image amplification of a nucleus and a cytoplasmic DNA-containing structure. (MN) Merging of fluorescent signals superimposed on the corresponding cellular images obtained by Nomarsky microscopy. Nucleus (n). Arrows indicate cytoplasmic DNA-containing structures. Bar scale corresponds to 8 *μ*m](JBB2010-734898.005){#fig5}

![Expression and identification of rEhODP1-168 polypeptide. (a) rEhODP1-168 polypeptide production was 1 mM IPTG induced in bacteria, and proteins were separated by 15% SDS-PAGE. Gel was Coomassie Brilliant Blue stained. Lane 1, protein molecular weight markers. Lane 2, uninduced bacteria. Lane 3, induced bacteria. (b) The induced recombinant protein was purified by IMAC using denaturing conditions. Fractions were analyzed by 15% SDS-PAGE and the gel was Coomassie Blue stained. Lane 1, protein molecular weight standards. Lane 2, total extract from IPTG-induced bacteria before the affinity chromatography. Lane 3, unbound proteins to the Ni^2+^-NTA-agarose column. Lane 4, proteins eluted with buffer D. Lane 5, proteins eluted with buffer E (see Materials and Methods). (c) Purified proteins were separated by 15% SDS-PAGE, transferred to a nitrocellulose membrane and stained with Ponceau Red. Lane 1, prestained protein molecular weight markers. Lane 2, proteins in fraction D. (d) Western blot of proteins shown in lane 2 in (c), immunodetected with monoclonal anti-6His tag antibodies. (e) 2D gel electrophoresis of proteins eluted in fraction D from the Ni^2+^-NTA-agarose column. Proteins were stained with Coomassie Brilliant Blue. (f) Amino acid sequence of the expected rEhODP1-168 that corresponds to the spot shown in (e) (arrow). Underlined are the peptides identified by MALDI-TOF mass spectrometry. Arrows indicate the expected rEhODP1-168 polypeptide. Arrowheads show an induced polypeptide that was copurified with rEhODP1-168.](JBB2010-734898.006){#fig6}

![EhODP1 was localized in an EhkO-enriched fraction. (a) EhkOs were purified by differential centrifugation and through a Nycodenz discontinuous gradient from exponentially growing trophozoites labeled with \[^3^H\]-Thymidine. Then, fractions were collected and their radioactivity content was measured. Data in graph represents total radioactivity incorporated in DNA within each fraction. (b) Western blot of proteins separated by 10% SDS-PAGE using rat anti-rEhODP1 antibodies. Lane 1, prestained molecular weight standards; lane 2, fresh total trophozoite extracts; lane 3, frozen total trophozoite extracts; lane 4, EhkOs-enriched fraction corresponding to fraction 9 in (a); lane 5, preimmune serum used with fresh total trophozoite extracts. Arrow indicates the 150 kDa polypeptide. Arrowhead shows the 70 kDa band.](JBB2010-734898.007){#fig7}

![Subcellular localization of EhODP1 in EhkOs using anti-rEhODP1-168 antibodies and laser confocal microscopy. Fixed and permeabilized*E. histolytica*trophozoites were incubated with anti-rEhODP1-168 antibodies and fluorescein-labeled goat anti-rat antibodies, stained with PI and observed through a laser confocal microscope. (a) Immunolocalization of EhODP1 in EhkOs. (b) Negative control performed with preimmune serum. (PI) Cells stained with propidium iodide (red channel). (*α*-rEhODP1) EhODP1 protein immunolocalized in EhkOs with anti-rEhODP1-168 antibodies (green channel). (M) Merging of red and green fluorescent signals. Arrows indicate EhkOs. Squares show an image amplification of a cytoplasmic DNA-containing structure. The bar scale corresponds to 8 *μ*m.](JBB2010-734898.008){#fig8}

###### 

Comparison of the *E. histolytica* organellar DNA polymerase 1 (EhODP1) with DNA polymerases mostly encoded in mitochondrial plasmids.

  Organism             AN       Cod           L      I    S    AA    Score   E
  -------------------- -------- ------------- ------ ---- ---- ----- ------- ----------
  *T. vaginalis*       A2ECW5   nd            1232   33   53   929   447     1e^−123^
  *F. velutipes*       Q9GBS2   M             925    22   40   781   116     8e^−24^
  *Gelasinospora sp*   003684   M (Gel-kal)   987    21   39   847   116     8e^−24^
  *A. immersus*        P22374   M (Pa12)      1202   25   42   494   108     2e^−21^
  *C. perniciosa*      Q6U7U2   M             899    21   39   642   107     4e^−21^
  *S. kluyveri*        Q09038   M (pSKL)      999    24   40   654   102     1e^−19^
  *N. intermedia*      P33538   M (kalilo)    969    22   41   514   102     1e^−19^
  *P. etchellsii*      Q9C130   C (pPE1B)     1013   23   41   541   78      3e^−12^
  *K. lactis1*         P09804   M (pGKL-1)    995    24   39   771   97      7e^−18^
  *K. lactis2*         P05468   M (pGKL-2)    994    22   41   668   92      2e^−16^
  *P. purpurea*        O99973   M             620    23   41   541   78      3e^−12^
  *A. aegerita*        O78938   M             571    22   41   515   83      1e^−13^
  *P. kluyveri*        O21376   M (pPK2)      1118   20   39   531   63      1e^−07^
  *M. conica*          Q9TEH5   M (pMC3-2)    901    28   44   216   60      1e^−07^
  *P. anserina*        Q01529   M (pAL2-1)    1197   22   40   614   59      2e^−06^

AN (UniProtKB/TrEMBL Accession Number). Cod (Coded in mitochondrion (M) or cytoplasm (C) or not determined (nd)). L (Total aa length of the protein). I (Identity). S (Similarity). E (Expected value).
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